#VisualAbstract: Aromatase inhibitors superior to tamoxifen for progression-free survival in HR⁺ advanced breast cancer
Click to read the study in the European Journal of Cancer.
Click to read the study in the European Journal of Cancer.
Click to read the study in JAMA Oncology.
Feb 26th – The incidence of advanced breast cancer in women ages 25-39 has increased from 1.53/100,00 in 1976 to ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.